Indian Pharma Sector To play a crucial role in Global Market

The Indian pharmaceutical sector is set to bolster its position in the global market, said K Raja Bhanu, director general of the Pharmaceuticals Export Promotion Council of India (Pharmexcil). During the closing day of iPHEX 2024, Bhanu emphasized...

Sunfox Bags Rs 15 crore in Pre-series Funding For Cardiac Innovations

Sunfox Technologies, the health tech startup known for its participation on Shark Tank India, has secured an extra Rs 15 crore in a pre-series funding phase. Existing investor Venture Catalyst led the round, with new investors including Finvolve...

Shilpa Medicare Concludes phase 1 trial for volume replacement therapy

Shilpa Medicare has effectively finished its phase 1 clinical trial for its leading product, sRbumin, a recombinant human albumin 20% (rHA). Human serum albumin is crucial for different medical interventions, including fluid replacement therapy...

Pharma Manufacturing & Automation Excellence Awards 2024: Honoring The Visionaries Behind Pharma's Transformational Growth

Driven by global demand, generics production, and increased domestic investment, India's pharma manufacturing sector has grown by 9% to 12% annually over the past two years. Automation in the industry has also surged, with 15% to 18% annual growth.

6th Annual Pharma Manufacturing & Automation Convention 2024

The pharma industry is undergoing a transformative evolution with the integration of advanced manufacturing technologies and automation systems. In the 2-day program 6th Annual Pharma Manufacturing and Automation Convention 2024.

US FDA Nods SmartAdjust technology for Individuals with type 2 Diabetes

The FDA broadened the uses of Insulet SmartAdjust, a technology for diabetes management, to include type 2 diabetes in adults over 18 years old, in addition to type 1 diabetes in individuals aged two and older. Software that automatically adjusts...

Bharat Biotech to Globally Market its Oral Cholera Vaccine

On Tuesday, Bharat Biotech announced that its oral cholera vaccine has successfully completed a late-stage trial and is preparing for a global launch, with plans to produce up to 200 million doses annually. The vaccine, named Hillchol, has receive...

Alembic Pharma Secures Approval to Manufacture Generic Psoriasis Drug

Alembic Pharmaceuticals announced on Monday that it has received approval from the US Food & Drug Administration (USFDA) to market a generic version of Betamethasone Valerate Foam, a medication used to treat moderate-to-severe psoriasis of the scalp.

Alkermes Commences Vibrance-2 phase 2 study of ALKS 2680

Alkermes plc has commenced the Vibrance-2 study, which is a phase 2 clinical trial assessing the safety and effectiveness of ALKS 2680 versus placebo in adult patients with narcolepsy type 2 (NT2). ALKS 2680 is a new, under investigation, oral...

Sun Pharma Launches Novel Treatment in India

Sun Pharmaceutical Industries Limited introduced tedizolid phosphate tablets 200 mg in India with the brand name "Starizo". Starizo (tedizolid phosphate) is a new antibiotic in the oxazolidinone class, prescribed for acute bacterial skin and skin...

© 2025 India Pharma Outlook. All Rights Reserved.